Ashish Gurav

Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam et al. · Immunity · 2014 · 2.3K citations · Full text

Life Sciences, Cancer Biology, Nutritional Sciences +14

SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer

Senthil Karunakaran, Sabarish Ramachandran, Veena Coothankandaswamy et al. · Journal of Biological Chemistry · 2011 · 206 citations · Full text

Medicine, Endocrinology, Oncology +17

RCAD/Ufl1, a Ufm1 E3 ligase, is essential for hematopoietic stem cell function and murine hematopoiesis

Mingming Zhang, Xinyuan Zhu, Yang Zhang et al. · Cell Death and Differentiation · 2015 · 183 citations

Life Sciences, Cell Biology, Molecular Biology +13

Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions

Ashish Gurav, Sathish Sivaprakasam, Yangzom D. Bhutia et al. · Biochemical Journal · 2015 · 157 citations · Full text

Life Sciences, Immunology, Oncology +17

An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis

Sathish Sivaprakasam, Ashish Gurav, Amy V. Paschall et al. · Oncogenesis · 2016 · 132 citations · Full text

Agriculture, Microbiology, Nutrition +15